“Intestinal Microflora” as Health Indicator, A National-level Research Project by Chula Doctors in Response to Problems of an Aging Society

Chula’s Faculty of Medicine pioneers Thailand’s first research work that studies “Intestinal Microflora Microbiome of the Aged” which gathers basic information at the national level to unlock the relationship between the wellness of the aged and intestinal microflora that can predict risks of diseases and health and the population’s wellbeing.

Designer Probiotic Treatment for Cancer Immunotherapy

Columbia Engineers have engineered probiotics to safely deliver immunotherapies within tumors, including nanobodies against two proven therapeutic targets—PD-L1 and CTLA-4. Continuously released by bacteria, the drugs continue to attack the tumor after just one dose, facilitating an immune response resulting in tumor regression. The versatile probiotic platform can also be used to deliver multiple immunotherapies simultaneously, enabling the release of effective therapeutic combinations within the tumor for more difficult-to-treat cancers like colorectal cancer.